1月5日，A股以放量大涨拉开2026年序幕，日成交额增至2.57万亿元，赚钱效应良好，4185只个股收红，传媒、医药生物、电子、证券、大消费等均表现 亮眼。 受访人士表示，国际流动性宽松、美元贬值、人民币升值及国内政策利好共振，今日A股放量大涨，资金从低股息权重切换至高景气成长，市场风险偏好 显著提升。短期强势有望延续，可逢低关注脑机接口、半导体等新兴产业，同时警惕技术性回调、海外不确定性与行业分化风险。 沪指12连阳 A股新年开门红：沪指12连阳，收涨1.38%报4023.42点；创业板指涨2.85%报3294.55点，深证成指涨逾2%；科创50飙升4.4%，沪深300、上证50、北证50 齐涨约2%。 交易量较上一个交易日放大5016亿元，日成交额增至2.57万亿元。杠杆资金方面，截至去年12月31日，沪深京两融余额为2.54万亿元。 盘面上，半导体、存储芯片、电子设备制造等科技主线大涨，生物医药、医疗器械、人脑工程、AI制药爆发，短剧互动亦表现活跃；银行、石油天然 气、天然气、页岩气等板块回落。 31个申万一级行业中26个飘红，石油石化、银行等板块微跌，传媒板块大涨，蓝色光标、天下秀、引力传媒、三七互娱 ...

市场每天都有几十只个股涨停，但未必都是机会。 龙虎榜是"明牌"，席位背后的关联性是"暗牌"。跟踪席位能让你看清是谁在主导行情，是机构在调仓， 还是游资在对倒出货。 龙虎榜不是拿来"跟买"的，而是拿来"拆解"的。知名席位上榜，自带吸粉效应，次日开盘往往有更高的 溢价。游资席位的分布能帮你分辨谁是"虫"，谁是"真龙"。 板块热度 A股今日喜迎2026年开门红，沪指12连阳，重新站上4000点大关。沪深两市成交额达到25675亿元，较 上一个交易日大幅放量5016亿元。行业板块呈现普涨态势，上涨股票数量接近4200只，近130只股票涨 停。 人脑工程概念股集体爆发，博拓生物、三博脑科等多只股票20cm涨停。脑机接口概念股飙涨，或与马 斯克近日重磅宣布的脑机接口设备"量产预告"有关。做投资就是要找那种能够改变时代的重大题材，那 种可以引领人类社会科技进步的题材。 龙虎榜主力动向 1、消闲派携手"章盟主"席位封板航天机电 消闲派是A股新生代游资中的标杆性人物，以稳健型超短著称，从20万起步到身家数亿，6年最大回撤 仅10%，其交易风格兼具快准狠的短线特质与稳如磐石的风控意识，核心风格可概括为"以首板为锚、 以情绪为核、 ...

谁也没有想到，2026年资本市场的首个热门赛道，会是脑机接口。 A股开年首个交易日，脑机接口板块（886047）便迎来放量暴涨，当日涨幅高达13.7%，成交金额突破 626亿元，创下阶段性新高。板块内掀起涨停潮，倍益康以30厘米涨停领涨，三博脑科、翔宇医疗、伟 思医疗等近20只个股收获20厘米涨停，博拓生物、道氏技术等多只概念股同步大幅冲高，赚钱效应全面 释放。这波强势行情的背后，核心催化因素直指马斯克的一则重磅表态。 2025年12月31日，马斯克在社交媒体平台发文宣布，其旗下脑机接口公司Neuralink计划于2026年启动脑 机接口设备的大规模生产，同时推进"更加精简和几乎完全自动化的外科手术流程"。 据其披露，新一代技术的核心突破在于电极丝可直接穿透硬脑膜无需切除，这一革新能显著降低手术创 伤与并发症风险，而自动化手术机器人已将单台手术时长从早期的6小时压缩至20分钟内，植入成本也 从百万美元级降至10万美元以内，为规模化落地奠定基础。 但热闹的行情背后，需警惕技术成熟度与商业化进度的错配。从行业现状来看，当前脑机接口仍处于临 床验证阶段，无论是侵入式路线的手术安全性验证，还是非侵入式路线的信号精度提 ...

1月5日，市场高开高走迎来2026年开门红，创业板指领涨，沪指重回4000点上方，录得十二连阳。截至收盘，沪指涨1.38%，收报4023.42点；深证成指涨 2.24%，收报13828.63点；创业板指涨2.85%，收报3294.55点。沪深两市成交额达到25463亿，较上一交易日大幅放量5011亿。 从板块来看，脑机接口、商业航天、科技成长三大主线全天领涨，点燃A股上攻情绪。脑机接口概念三十余只成分股涨停，三博脑科、美好医疗、创新医疗 涨停。商业航天概念反复活跃，雷科防务4连板，中国卫通5天3板。半导体产业链走强，亚翔集成、圣晖集成等多只科技成长股涨停。AI应用概念表现活 跃，蓝色光标2连板。保险板块爆发，新华保险、中国太保大涨续创历史新高。下跌方面，海南自贸概念集体大跌，海南发展跌停。 今日全市场共108股涨停，连板股总数14只，锋龙股份7连板，26股封板未遂，封板率为80%（不含ST股、退市股）。 一、板块异动 四、涨停揭秘 | | 金融界股灵通复盘(1.5) | | | | | --- | --- | --- | --- | --- | | 代码 | 简称 | 最终封板 | 几天几板 | 原因 | | ...

Group 1 - The A-share market opened positively in 2026, with the Shanghai Composite Index rising over 1% and the ChiNext Index increasing by more than 2%, driven by gains in technology, finance, and cyclical sectors [1][2] - The commercial aerospace sector is transitioning from a speculative concept to a core engine for national competition and economic transformation, with significant growth observed in the satellite internet segment [1][12] - The satellite industry ETF (159218) saw a substantial increase of 3.78%, with a record net inflow of 2.11 million shares, indicating strong investor interest in China's shift from experimental exploration to industrialized production [1][10][13] Group 2 - The brain-computer interface sector is experiencing a surge, with companies like Neuralink planning large-scale production in 2026, and the market is projected to grow to approximately $12.4 billion by 2034, with a compound annual growth rate of 17% [7][8] - The insurance sector showed robust performance, with total premium income reaching 57.63 billion yuan in the first eleven months of 2025, marking a year-on-year growth of 7.6% [10] - The commercial aerospace sector is expected to accelerate in 2026, with multiple rocket launches and the involvement of private companies, indicating a shift towards a dual-driven model of state-owned and private enterprises [12][19] Group 3 - The Chinese satellite internet industry is entering a practical phase, with significant advancements in satellite launches and the establishment of a competitive landscape against global players like SpaceX [16][19] - The anticipated breakthroughs in rocket manufacturing and the reduction of launch costs are expected to stimulate demand for satellite launches, making commercial aerospace economically viable [21][22] - The satellite industry ETF (159218) is positioned to capture the growth across the entire satellite value chain, with a focus on companies involved in satellite manufacturing, launch services, and downstream applications [24][26] Group 4 - 2026 is projected to be a pivotal year for China's commercial aerospace sector, with policy support, technological advancements, and capital market dynamics converging to create significant investment opportunities [29] - The development of "space infrastructure" is becoming increasingly important, with rocket launch capabilities and satellite constellations being likened to traditional infrastructure such as railways and ports [23][29] - The ETF investment approach is recommended for investors to participate in the aerospace sector's growth, given the complexities and high volatility associated with individual stocks [24]

21世纪经济报道记者易妍君 2026年，A股旗开得胜，三大股指在首个交易日（即1月5日）悉数上涨。 这一天，上证指数重返4000点之上，日线更是迎来罕见的12连阳，为"春季躁动"预期下的A股市场再添"一把火"。 市场热点轮番活跃，脑机接口、保险、存储器等题材相对强势；CRO、模拟芯片、基因检测、虚拟人等概念也有不错的表现。 展望后市，前海开源基金首席经济学家、基金经理杨德龙判断，2026年科技牛行情有望延续。 亦有受访人士向21世纪经济报道记者指出，A股接下来的表现将紧密围绕几个核心变量展开，如宏观稳增长政策的具体力度、美联储货币政策的实际节奏 等。 对于2026年的投资，机构倾向于在科技成长、先进制造、顺周期与消费等方向挖掘机会。 | 内地股票 広 | | | | --- | --- | --- | | 行情 | 资金净流入 | 涨跌分布 | | 上证指数 | 深证成指 | 科创综指 | | 4023.42 | 13828.63 | 1695.84 | | +54.58 +1.38% | +303.61 +2.24% | +59.14 +3.619 | | 万得全A | 创业板指 | 北证50 | | 65 ...

2026年迎"开门红"——1月5日，A股三大指数均涨超1%，沪指收报4023.42点，重新站上4000点整数大关。自去年12月17日至今，沪指日K线已录得12连阳， 创下1996年±10%涨跌停板制度实施以来的连阳纪录。 脑机接口集体沸腾，板块中爱朋医疗、三博脑科、博拓生物、翔宇医疗、美好医疗等20股涨停。 港股通医疗ETF富国涨超7%；港股通创新药ETF、恒生生物科技ETF、港股通医药ETF易方达、恒生生物科技ETF、恒生医药ETF、港股创新药ETF基金、港 股通创新药ETF嘉实、恒生生物科技ETF鹏华、恒生生物科技ETF易方达、港股创新药50ETF、港股通创新药ETF、工银恒生创新药ETF、港股医疗ETF、港 股通医药ETF、香港医药ETF涨超6%。 | 15929 / SZ | 港股退刨萧约ヒl┣用万 | 5.13% | | --- | --- | --- | | 520880.SH | 港股通创新药ETF | 5.42% | | 159102.SZ | 港股通生物科技ETF | 5.42% | | 159316.SZ | 港股通创新药ETF易方达 | 5.41% | | 159286.SZ | 港股创 ...

2026年第一个交易日，A股早盘高开高走，上证指数盘中重回4000点。 题材上，AI、保险、医药等多点开花。脑机接口板块早盘掀起涨停潮，倍益康30cm涨停，三博脑科、美好医疗、翔宇医疗20cm涨停。 开源证券策略研究团队在研报中表示，当前A股市场或已正式进入2026年"春季躁动"的预热与布局窗口。不过，与过往普涨行情不同，本轮躁动在宏观经济 数据尚待验证、增量资金稳步入场的背景下，呈现出鲜明的"结构先行、机会轮动"特征，包括商业航天、机器人、石油化工、有色等。 | | | Wind热门概念指数 | | | | | | --- | --- | --- | --- | --- | --- | --- | | 脑机接口 | 医疗器械 | 存储器 | 保险 | CRO | 保险 | 医疗保健 | | 9.95% | 6.83% | 6.77% | 6.72% | 5.39% | 6.20% | 5.46% | | 医疗服务 | 摩尔线程 | 模拟芯片 | 基因检测 | 虚拟人 | 电脑硬件 | 化肥农药 | | 5.28% | 5.23% | 4.93% | 4.89% | 4.77% | 3.75% | 3.42% ...

Market Performance - The three major indices collectively rose, with the Shanghai Composite Index increasing by 1.07%, the Shenzhen Component Index by 1.87%, and the ChiNext Index by 2.15% [1] - Over 3,800 stocks in the two markets experienced gains, with a total trading volume of 1.64 trillion [1] Sector Highlights - The brain-computer interface concept surged, with a notable increase of 12.56%, leading to over ten stocks hitting the 20% daily limit up, including Sanbo Brain Science, Botao Biology, Daoshi Technology, and Xiangyu Medical [3] - The commercial aerospace sector remained active, with China Satellite Communications achieving three consecutive trading limits in five days [3] - The insurance sector strengthened, with Xinhua Insurance and China Pacific Insurance both reaching historical highs [3] - The semiconductor industry chain showed robust performance, with stocks like Yaxiang Integration and Shenghui Integration hitting the daily limit up [3] Declining Sectors - The Hainan Free Trade Zone concept faced a decline, dropping by 3.06%, with Hainan Development hitting the daily limit down [3] - Other sectors such as duty-free shops, airports, and tourism hotels followed suit, each experiencing declines of over 1% [3] - The oil, banking, and lottery sectors also faced downward pressure [3] Company News - Salt Lake Co. recently announced its 2025 performance forecast, expecting a net profit attributable to shareholders of 8.29 billion to 8.89 billion, representing a year-on-year growth of 77.78% to 90.65% [3] - In 2025, China has approved 76 innovative drugs for listing, setting a historical record, with total external authorization transaction amounts exceeding 130 billion [3]

Market Overview - The Shanghai Composite Index (SHCI) has strongly reclaimed the 4000-point mark, closing up 1.38% on January 5, 2026, with a total trading volume exceeding 25.67 billion yuan, an increase of 5.02 billion yuan from the previous day [12][29]. - A total of 128 stocks hit the daily limit up, with over 4100 stocks rising across the market [12][29]. Key Sectors - The technology sector, particularly the brain-computer interface (BCI) and domestic chip industries, saw significant gains. Notably, stocks like Sanbo Brain Science and Meihao Medical surged to their daily limits [12][13]. - The BCI sector led the market rally, with nearly 30 stocks within this category hitting the limit up, driven by announcements from Neuralink regarding large-scale production of BCI devices by 2026 [12][13]. - The domestic chip sector also performed well, with storage chips leading the charge. Longxin's prospectus indicated expected revenues of 55-58 billion yuan for 2025, with net profits projected between 2-3.5 billion yuan [12][13]. Investment Trends - The market sentiment is buoyed by the anticipated growth in AI applications, the "going out" trend, and policies aimed at reducing internal competition [9]. - Goldman Sachs has recommended a high allocation to A-shares and Hong Kong stocks in 2026, predicting annual growth of 15% to 20% for the Chinese stock market in 2026 and 2027 [9]. Performance Metrics - The SHCI achieved a record of 12 consecutive daily gains from December 17, 2025, to January 5, 2026, marking the longest streak since March 1992 [1][2]. - The market's strong performance is reflected in the significant increase in trading volume and the number of stocks hitting their daily limits, indicating robust investor interest [12][29]. Sector Analysis - The aerospace sector continued its strong momentum, with stocks like Leike Defense achieving multiple consecutive gains, supported by government announcements regarding military advancements [12][13]. - The AI large model sector also saw a rise, with companies like Nansheng Co. and Liou Co. recording consecutive gains, fueled by partnerships and investments in AI technologies [12][13].